Medicare Part D plans dont typically cover weight-loss drugs
This appointment covers your full medical history, current medications, weight history, metabolic health markers, and personal goals
re-educating on updated criteria, or negotiating a special arrangement)
The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns
According to the Wegovy SmPC, nausea and vomiting are among the most frequently reported adverse effects, with nausea occurring in approximately 44% and vomiting in about 24% of patients in clinical trials
